Viewing Study NCT02851433


Ignite Creation Date: 2025-12-25 @ 2:55 AM
Ignite Modification Date: 2026-02-25 @ 6:53 PM
Study NCT ID: NCT02851433
Status: COMPLETED
Last Update Posted: 2017-10-10
First Post: 2016-07-28
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Evaluate the Protective Effect of Conditioning With Sevoflurane on the Myocardium
Sponsor: Centre Hospitalier Universitaire Dijon
Organization:

Study Overview

Official Title: Evaluate the Protective Effect of Conditioning With Sevoflurane Versus Propofol on the Myocardium in Scheduled Aortic Valve Replacement Surgery
Status: COMPLETED
Status Verified Date: 2017-10
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: SUPRA
Brief Summary: Heart surgery is a considerable source of stress for the myocardium that must be minimized.

Troponin Ic is a reliable marker to determine the level of this myocardial stress.

Studies have shown that post-conditioning with AVH has a protective effect on the myocardium, if the treatment is initiated at the start of the ischemia.

The aim of this study is to evaluate the protective effect on the myocardium (by measuring troponin levels) of the association of pre-conditioning and post-conditioning with Sevoflurane (AVH) sedation administered during and after scheduled surgery for valve replacement, via sternotomy or thoracotomy compared with total intravenous anaesthesia with Propofol.
Detailed Description: None

Study Oversight

Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?: